Pharmaceuticals & Biotech

Simon-Kucher advises pharmaceutical and biotechnology clients on their most challenging strategic priorities with a focus on four core areas: strategy, marketing, sales and pricing/market access. We have helped clients:

• Of all sizes and experience, from the largest players in the industry to an ever expanding number of companies commercializing their first products
• At any stage of the product lifecycle, from early stage asset prioritization to Phase II/III planning; and from launch strategy readiness through life cycle management and loss of exclusivity planning
• In over 60 countries around the world, our substantial global footprint allows us to support our clients’ success in the big seven markets (the USA, France, Germany, Italy, Spain, the UK, and Japan) to numerous important growth markets (Brazil, China, south east Asia and many others)
• Across the entire customer network, we can give pharmaceutical and biotechnology companies actionable insights, strategy and advice to navigate the complex interactions between their most important customers, including (but not limited to): payers, hospitals/institutions, physicians, pharmacists, patients, and distributors
• Both develop strategy and build capabilities, we partner with our clients to both advance their strategic thinking and to enable world-class performance

Simon-Kucher has a clear focus on TopLine Power. We help our clients grow their business, communicate the value of their products; better meet the needs of their customers; attain patient access for their products; and achieve their strategic goals.

A selection of core Simon-Kucher projects are shown below:

Opportunity Definition:

• Market landscaping
• Business potential assessment / forecasting
• Asset prioritization
• Commercial due diligence
• Go-to-market strategy

Value Delivery:

• Marketing excellence
• Payer-rationalized trial design
• Customer segmentation and targeting
• Value story development
• Positioning strategy

Customer Engagement:

• Sales excellence
• Managed markets strategy
• Key account management
• Mock negotiations and training
• Tender management and planning

Pricing & Access Strategy:

• Market access strategy
• Pricing and contracting strategy
• Managed entry agreements
• Big deal management
• Lifecycle price and discount management

Capability Building:

• Pricing excellence
• Market access operations
• Contracting process development
• Tender capability building
• Commercial launch readiness

Our global expert team has unrivalled expertise in helping pharmaceutical and biotechnology companies achieve their strategic goals while improving the health of patients around the world.